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Research into the causes of both
sporadic and familial Parkinson’s disease
have led to the idea that a key risk factor
might be mitochondrial dysfunction. The
neurons of the substantia nigra, which are
specifically lost in Parkinson’s disease,
seem to be especially vulnerable to the
effects of mitochondrial damage. Recent
work showed that the protein Parkin,
which is mutated in some forms of familial
Parkinson’s disease, is recruited from the
cytoplasm to damaged mitochondria and
that this leads to the breakdown of the
mitochondria by processes acting within
the cell (autophagy).
The mitochondrial membrane protein
PINK1 is also mutated in some forms of
familial Parkinson’s disease. In a new
study in this issue of PLoS Biology, Youle
and colleagues address the question of how
Parkin recognises damaged mitochondria,
and they find a crucial role for PINK1.
Damaged mitochondria cannot main-
tain the potential difference across their
inner membrane. This membrane depo-
larization can be mimicked experimentally
by treating cells with CCCP—a ‘‘proto-
nophore’’ that pokes a hole in the
membrane, making it more permeable to
protons. To investigate the role of PINK1
in the cell’s response to mitochondrial
damage, the authors treated cultured cells
with CCCP and found that PINK1
accumulated on the depolarized mito-
chondria over several hours. In cells that
contained some normal, polarized mito-
chondria and some depolarized ones,
PINK1 accumulated specifically on the
depolarized mitochondria and Parkin
was recruited to those same damaged
mitochondria.
PINK1 might accumulate in damaged
mitochondria because of increased synthe-
sis and/or reduced degradation of the
protein. To investigate which mechanism
might be responsible, the authors first
allowed PINK1 to accumulate in the
presence of CCCP for three hours. They
then washed out the CCCP and saw a
rapid reduction in the amount of PINK1,
suggesting that PINK1 degradation was
inhibited when the mitochondria were
depolarized. Addition of a proteasome
inhibitor to untreated cells caused the
accumulation of a cleavage product of
PINK1 that was also found at high levels
after CCCP washout in the inhibitor-
treated cells, but at lower levels during
CCCP treatment. This is consistent with
the accumulation of PINK1 on depolar-
ized mitochondria being due, at least
partly, to reduced degradation of PINK1.
By contrast, the authors found that
depolarization of mitochondria by CCCP
did not lead to increased transcription of
PINK1. They propose a two-step model
for PINK1 processing in which the first
PINK1 cleavage step is voltage-dependent
but proteasome-independent and is fol-
lowed by complete degradation of the
cleavage product by the proteasome.
Youle and colleagues found that Parkin
was not required for accumulation of
PINK1 on depolarized mitochondria, but
that Parkin could not be recruited to
depolarized mitochondria in the absence
of PINK1. In addition, whereas expression
of ectopic Parkin could induce autophagic
destruction of depolarized mitochondria in
normal cells, it could not do so in cells
lacking PINK1. These findings indicate
that PINK1 accumulates on depolarized
mitochondria before Parkin and that both
are required for the subsequent autophagy
of mitochondria.
The authors induced ectopic overex-
pression of PINK1 and found that this
accelerated the recruitment of Parkin and
loss of mitochondria in the presence of
CCCP. They then generated a chimeric
protein that had the active part of PINK1
and a membrane anchor from another
protein, but that lacked a cleavage site. As
expected, this protein was more stable
than wild-type PINK1. Its presence led to
the recruitment of Parkin to mitochondria
that were not depolarized and also to
increased mitochondrial autophagy. Ex-
cessive PINK1 accumulation on mito-
chondrial membranes is therefore suffi-
cient to recruit Parkin and activate
mitochondrial autophagy, even in the
absence of membrane depolarization.
A variety of mutations in the PINK1 and
Parkin genes cause early-onset Parkinson’s
disease in humans. This paper reports that
these mutations disrupt distinct steps in
Parkin recruitment to mitochondria and
induction of autophagy. It is easy to
imagine that this could lead to accumula-
tion of damaged mitochondria in cells.
The increased vulnerability of the neurons
in the substantia nigra to mitochondrial
damage might be because greater oxida-
tive stress is found here than elsewhere in
the brain and/or because neurons do not
regenerate by division and turnover as do
other cell types.
These findings provide important in-
sights into how Parkin and PINK1 func-
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PINK1 (labeled in green by GFP, top
panels) accumulates on mitochondria
(labeled in red with mitotracker, bottom
panels) when they are uncoupling with
CCCP for 60 minutes or otherwise im-
paired, signalling mitochondrial dys-
function to Parkin, which triggers their
elimination.
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mutations might lead to Parkinson’s dis-
ease. Further investigations of mitochon-
drial turnover in the neurons of the
substantia nigra should lead to a fuller
understanding of this process and might
identify potential therapeutic targets for
the treatment of the disease.
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